CIBC Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-28,108
Closed -$2.25M 998
2016
Q4
$2.25M Buy
28,108
+757
+3% +$60.1K 0.02% 364
2016
Q3
$2.18M Sell
27,351
-1,909
-7% -$154K 0.02% 360
2016
Q2
$2.28M Buy
29,260
+564
+2% +$40.2K 0.02% 340
2016
Q1
$1.58M Buy
28,696
+577
+2% +$31.4K 0.01% 426
2015
Q4
$1.74M Sell
28,119
-2,249
-7% -$142K 0.01% 394
2015
Q3
$1.92M Buy
30,368
+162
+0.5% +$11.6K 0.02% 361
2015
Q2
$2.21M Buy
30,206
+1,177
+4% +$85K 0.02% 356
2015
Q1
$1.9M Buy
29,029
+792
+3% +$52.7K 0.01% 392
2014
Q4
$1.84M Sell
28,237
-8,845
-24% -$570K 0.01% 392
2014
Q3
$2.23M Sell
37,082
-210
-0.6% -$13.7K 0.01% 376
2014
Q2
$2.58M Sell
37,292
-1,290
-3% -$83.6K 0.01% 354
2014
Q1
$2.52M Sell
38,582
-1,994
-5% -$130K 0.01% 358
2013
Q4
$2.51M Sell
40,576
-4,126
-9% -$239K 0.02% 345
2013
Q3
$2.4M Buy
44,702
+11
+0% +$567 0.02% 330
2013
Q2
$2.04M Buy
+44,691
New +$1.94M 0.01% 361

Other funds holding STJ

CIBC Asset Management's STJ Position: Q1 2017 in Review

CIBC Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 28,108 shares — an estimated $2.25M sold.

CIBC Asset Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $2.58M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • CIBC Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • CIBC Asset Management sold 28,108 St Jude Medical shares in Q1 2017, an estimated $2.25M.
  • CIBC Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • CIBC Asset Management's St Jude Medical position peaked at $2.58M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on CIBC Asset Management's 13F filing for Q1 2017, filed 15 May 2017.